DECR2, a 2,4‐dienoyl‐CoA reductase 2, was reportedly involved in cell proliferation in prostate cancer cell lines, since lentiviral vector‐mediated overexpression intensified cell growth [28]. The gene discussed is DECR2; the disease is prostate carcinoma.